Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

PHARMACEUTICAL HEALTH LIMITED

US

Last updated May 30, 2026

What PHARMACEUTICAL HEALTH LIMITED makes

Pharmaceutical Health Limited manufactures synovial fluid supplementation media designed to restore joint lubrication and cushioning, primarily for intra-articular use in osteoarthritis treatment. These products include hyaluronic acid-based formulations such as Orthovisc, Supartz, Synvisc, and Euflexxa, which are administered via direct joint injections to alleviate pain and improve mobility.

The company’s portfolio is classified under FDA’s Class III medical devices, requiring premarket approval (PMA) due to their intended use in treating significant conditions. These products are listed in the FDA’s Unique Device Identifier (UDI) database, ensuring traceability and regulatory compliance. The manufacturer operates from the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Pharmaceutical Health Limited manufacture?

Pharmaceutical Health Limited specializes in synovial fluid supplementation media, specifically hyaluronic acid-based formulations. These devices are designed to restore joint lubrication and cushioning, primarily for intra-articular use in treating osteoarthritis. Examples include Orthovisc, Supartz, Synvisc, and Euflexxa, which are injected directly into joints to reduce pain and improve mobility.

Where is Pharmaceutical Health Limited based?

The company is headquartered in the United States. This location aligns with its regulatory obligations, including compliance with FDA requirements for its Class III devices.

Which regulatory registries list Pharmaceutical Health Limited’s devices?

The company’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for synovial fluid supplementation media, which are classified under Class III—requiring strict regulatory oversight.

How are Pharmaceutical Health Limited’s devices classified by regulatory authorities?

Pharmaceutical Health Limited’s synovial fluid supplementation media fall under FDA’s Class III category. This classification is due to their intended use in treating significant medical conditions like osteoarthritis, necessitating premarket approval (PMA) to ensure safety and effectiveness before commercialization.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
LinkedIn
—
Facebook
—
Phone
+441332770202
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
216903276

Catalogue (5)

DeviceModel / ReferenceRegistriesClassStatus
Orthovisc NA
FDA UDI
Class IIIActive
Supartz NA
FDA UDI
Class IIIActive
Synvisc 5 Count
FDA UDI
Class IIIActive
Euflexxa NA
FDA UDI
Class IIIActive
Synvisc NA
FDA UDI
Class IIIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.